[1]
2018. Omalizumab Dose Step-Up and Treatment Response in Patients with Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU): Results from the OPTIMA Study. SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S52. DOI:https://doi.org/10.25251/skin.2.supp.52.